115 related articles for article (PubMed ID: 1407397)
1. N-methyl-D-aspartate receptors in the retina: 3-[(+/-)-2-carboxypiperazin- 4-yl]-propyl-1-phosphonic acid (CPP) binding studies.
López-Colomé AM; Somohano F
Neuropharmacology; 1992 Jun; 31(6):577-84. PubMed ID: 1407397
[TBL] [Abstract][Full Text] [Related]
2. Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.
Murphy DE; Schneider J; Boehm C; Lehmann J; Williams M
J Pharmacol Exp Ther; 1987 Mar; 240(3):778-84. PubMed ID: 3031274
[TBL] [Abstract][Full Text] [Related]
3. Localization of N-methyl-D-aspartate receptors in the rat striatum: effects of specific lesions on the [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid binding.
Samuel D; Errami M; Nieoullon A
J Neurochem; 1990 Jun; 54(6):1926-33. PubMed ID: 2159977
[TBL] [Abstract][Full Text] [Related]
4. Effect of cerebral hypoxia on NMDA receptor binding characteristics after treatment with 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) in newborn piglets.
Fritz KI; Groenendaal F; McGowan JE; Mishra OP; Delivoria-Papadopoulos M
Brain Res; 1996 Aug; 729(1):66-74. PubMed ID: 8874877
[TBL] [Abstract][Full Text] [Related]
5. Modulation of [3H]3-((+-)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP) binding by ligands acting at the glycine and the polyamine sites of the rat brain NMDA receptor complex.
Porter RH; Briggs RS; Roberts PJ
Eur J Pharmacol; 1992 Sep; 227(1):83-8. PubMed ID: 1426025
[TBL] [Abstract][Full Text] [Related]
6. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
[TBL] [Abstract][Full Text] [Related]
8. Action of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP): a new and highly potent antagonist of N-methyl-D-aspartate receptors in the hippocampus.
Harris EW; Ganong AH; Monaghan DT; Watkins JC; Cotman CW
Brain Res; 1986 Sep; 382(1):174-7. PubMed ID: 2876750
[TBL] [Abstract][Full Text] [Related]
9. 3-((+/-)2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) more potently antagonizes the high-affinity Mg2+ binding site on the N-methyl-D-aspartate/phencyclidine receptor ion channel complex than the L-glutamate recognition site.
Hatta K; Yamamato T; Hori T; Okuwa M; Moroji T
Neurosci Lett; 1991 Apr; 124(2):229-31. PubMed ID: 1712440
[TBL] [Abstract][Full Text] [Related]
10. Characterization of quisqualate-type L-glutamate receptors in the retina.
López-Colomé AM; Somohano F
Brain Res; 1987 Jun; 414(1):99-108. PubMed ID: 2887240
[TBL] [Abstract][Full Text] [Related]
11. Solubilization and partial purification of 3-((+-)-2-carboxypiperazine-4-yl)-[1,2-3H]propyl-1-phosphonic acid recognition proteins from rat brain synaptic membranes.
Cunningham MD; Michaelis EK
J Biol Chem; 1990 May; 265(14):7768-78. PubMed ID: 1970819
[TBL] [Abstract][Full Text] [Related]
12. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
[TBL] [Abstract][Full Text] [Related]
13. 3-[(+-)-2-carboxypiperazin-4-yl]propyl-1-phosphonic acid recognizes two N-methyl-D-aspartate binding sites in rat cerebral cortex membranes.
van Amsterdam FT; Giberti A; Mugnaini M; Ratti E
J Neurochem; 1992 Nov; 59(5):1850-5. PubMed ID: 1357101
[TBL] [Abstract][Full Text] [Related]
14. Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors.
Christoffersen CL; Meltzer LT
Neuroscience; 1995 Jul; 67(2):373-81. PubMed ID: 7545793
[TBL] [Abstract][Full Text] [Related]
15. Characterization of organophosphate interactions at N-methyl-D-aspartate receptors in brain synaptic membranes.
Johnson PS; Michaelis EK
Mol Pharmacol; 1992 Apr; 41(4):750-6. PubMed ID: 1533269
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of NMDA receptors labelled with [3H]3-((+-)-2-carboxypiperazin-4-yl) propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains.
Porter RH; Cowburn RF; Alasuzoff I; Briggs RS; Roberts PJ
Eur J Pharmacol; 1992 Mar; 225(3):195-201. PubMed ID: 1387617
[TBL] [Abstract][Full Text] [Related]
17. Autoreceptor regulation of glutamate and aspartate release from slices of the hippocampal CA1 area.
Martin D; Bustos GA; Bowe MA; Bray SD; Nadler JV
J Neurochem; 1991 May; 56(5):1647-55. PubMed ID: 1672884
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
Benveniste M; Mayer ML
Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
[TBL] [Abstract][Full Text] [Related]
19. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.
Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA
Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125
[TBL] [Abstract][Full Text] [Related]
20. Presence of the binding of a variety of ligands related to ionotropic excitatory amino acid receptors in rat retina.
Zuo P; Ogita K; Yoneda Y
Brain Res; 1992 Mar; 576(1):168-72. PubMed ID: 1381259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
